Products (2)
Resources (13)

"CCL4/MIP-1 beta" has 13 results in Resources.

Results per Page:

Cancer Immunotherapy Dendritic Cell Subsets

Product Categories

Plasmacytoid dendritic cells (pDC) reside in the circulation, extravasate to inflammatory sites, and traffic to draining lymph nodes to initiate adaptive immune responses. Mature pDC induce T cell survival, Th1 bias, cytotoxic T lymphcyte (CTL) activity, natural killer cell (NK) cytotolytic activity, maturation of myeloid DC, and development of plasma cells. They are efficient at antigen...

More Info

Modified Chemokines Exhibit Altered Potency and Specificity

Product Highlights

Chemokines are small secreted proteins that function in leukocyte trafficking, recruitment, and activation and have a role in many pathophysiological processes such as infectious and autoimmune diseases, inflammation, cancer, and vascular disease. Naturally occurring modifications, such as N-terminal truncation, can affect the biological potency and the receptor specificity of chemokines. R&D...

More Info

Assays for analytes represented in the Mouse Cytokine Array Kit, Panel A

Technical Resource

Analyte Quantikine® ELISA Kits DuoSet® ELISA Development Systems CXCL13/BLC/BCA-1 MCX130 DY470 C5a   DY2150 G-CSF MCS00 DY414 GM-CSF MGM00 DY415 CCL1/I-309/TCA-3   DY845 CCL11/Eotaxin MME00 DY420 ICAM-1 MIC100 DY796 IFN-gamma MIF00 DY485 IL-1...

More Info

Human Cytokine Array Kit

Product Categories

Human Cytokine Array Kit, Panel A Ordering Information Introduction R&D Systems Human Cytokine Array, Panel A (Catalog # ARY005) is a rapid, sensitive, and economical tool used to simultaneously detect the relative levels of 36 different cytokines, chemokines, and acute phase proteins in a single sample. No specialized equipment is necessary. Sample Data Product Insert (PDF,...

More Info

Mouse Cytokine Antibody Array, Panel A

Product Categories

Mouse Cytokine Antibody Array, Panel A Ordering Information Introduction R&D Systems Mouse Cytokine Array, Panel A (Catalog # ARY006) is a rapid, sensitive, and economical tool used to simultaneously detect the relative levels of 40 different cytokines, chemokines, and more in a single sample. No specialized equipment is necessary Sample Data Product Insert (PDF, 116K) Protocol...

More Info

Assays for analytes represented in the Human Cytokine Panel A

Product Categories

Analyte Quantikine® ELISA Kits Quantikine® HS (High Sensitivity) ELISA Kits QuantiGlo® Chemiluminescent ELISA Kits DuoSet® ELISA Development Systems CXCL5/ENA-78 DX000     DY254 FGF...

More Info

Assays for analytes represented in the Human Cytokine Array Kit, Panel A

Technical Resource

Analyte Quantikine® ELISA Kits Quantikine® HS (High Sensitivity) ELISA Kits QuantiGlo® ELISA Kits DuoSet® ELISA Development Systems C5a       DY2037 CD40 Ligand DCDL40     DY617 G-CSF DCS50 HSTCS0   DY214 GM-CSF DGM00 HSGM0   DY215 CXCL1/GRO...

More Info

Cancer Immunotherapy: Dendritic Cell Isolation/Expansion

Product Categories

Expand your dendritic cell (DC) cultures with our CellXVivo™ Human Monocyte-derived DC Differentiation Kit with an optimized protocol and optimized reagents. Or you can use our specially-designed StemXVivo® Serum-Free Dendritic Cell Base Media supplemented with our high-quality recombinant Cytokines and Growth Factors. For DC vaccine preparation with more rigorous documentation, take advantage...

More Info

Multiple Sclerosis: Immune Cell Access to the Central Nervous System

Article

First Published in R&D Systems' 2006 Catalog Contents Multiple Sclerosis Etiology Pathology Blood-Brain Barrier Adhesion Molecules Tight Junctions Selectins Ig Superfamily Cell Adhesion Molecules ICAM-1 VCAM-1 PECAM-1 Integrins alphaLbeta2/LFA-1 alpha4beta1/VLA-4 Chemokines Chemokine Receptors Matrix Metalloproteinases MMP-9 Conclusion Multiple sclerosis...

More Info

Immune Checkpoint Blockade: Blocking Antibodies

Product Highlights

Blockade of immune checkpoint molecules, such as CTLA-4 and PD-1/PD-L1, is a promising therapeutic approach for cancer treatment. Unfortunately, blocking CTLA-4 or PD-1/PD-L1 is not universally successful across different cancer types and patients. It is thought that co-targeting multiple checkpoint molecules simultaneously could improve the effectiveness of this strategy. Take...

More Info
Pageof 2